Page last updated: 2024-11-03

riluzole and Rett Syndrome

riluzole has been researched along with Rett Syndrome in 1 studies

Riluzole: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.

Rett Syndrome: An inherited neurological developmental disorder that is associated with X-LINKED INHERITANCE and may be lethal in utero to hemizygous males. The affected female is normal until the age of 6-25 months when progressive loss of voluntary control of hand movements and communication skills; ATAXIA; SEIZURES; autistic behavior; intermittent HYPERVENTILATION; and HYPERAMMONEMIA appear. (From Menkes, Textbook of Child Neurology, 5th ed, p199)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tsai, SJ1

Other Studies

1 other study available for riluzole and Rett Syndrome

ArticleYear
Is riluzole a potential therapy for Rett syndrome?
    Medical hypotheses, 2015, Volume: 85, Issue:1

    Topics: Humans; Models, Theoretical; Neuroprotective Agents; Rett Syndrome; Riluzole

2015